Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NS5A-IN-3 (Compound 15) serves as a potent NS5A inhibitor, displaying exceptionally high efficacy against HCV genotype 1b, enhanced activity towards genotype 3a (GT 3a), and substantial metabolic stability. It also demonstrates a superior resistance barrier compared to daclatasvir in genotype 1b [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 383,500 |
50 mg | 約8-10 週間 | ¥ 500,500 |
100 mg | 約8-10 週間 | ¥ 643,000 |
説明 | NS5A-IN-3 (Compound 15) serves as a potent NS5A inhibitor, displaying exceptionally high efficacy against HCV genotype 1b, enhanced activity towards genotype 3a (GT 3a), and substantial metabolic stability. It also demonstrates a superior resistance barrier compared to daclatasvir in genotype 1b [1]. |
分子量 | 784.86 |
分子式 | C44H44N6O8 |
CAS No. | 2764786-56-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NS5A-IN-3 2764786-56-1 Microbiology/Virology Proteases/Proteasome HCV Protease Inhibitor inhibitor inhibit